Kage Apothecare LLC

Kage Apothecare (Kage) develops and commercializes novel dietary supplements and medical food formulations. Kage's product portfolio is highly specialized, patented and evidence-based. The Company is building build brands that address unmet patient need as well as aspects of chronic health issues, while appealing to the therapeutic sensibilities of mainstream physicians Our commitment is to your health by creating products of the highest quality possible. When you feel better, we feel better. Recently launched, Nervia® is Kage's lead product and the cornerstone of an expanding product line. Based on a soft-gel delivery platform that works across multiple pathways, Nervia®'s initial formulation supports nerve health, inflammation and tissue repair. Scientific research shows the Nervia® composition blocks key inflammatory cytokines (small protein signaling molecules in the body), reduces various types of oxidative stress and supports the body's own immune response. Initially formulated for peripheral neuropathic pain and discomfort, post launch reports from physicians and patients alike indicate that Nervia® appears to have beneficial effects against joint disease and inflammation as well as sports-related injuries.